Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fending Off The “Fallback”: Medicare Rx Bans Marketing Of Backup Plans

Executive Summary

Marketing restrictions on contractors offering "fallback" prescription drug plans under Medicare are one reason drug manufacturers are comfortable that the program will not evolve into a government administered benefit

You may also be interested in...



Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA

Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25

Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA

Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25

Medicare Rx “Fallback” Plans Ensured Small Role Under CMS Rule

Entities administering a Medicare prescription drug "fallback" plan in a single U.S. region will be prohibited from bidding as stand-alone PDPs anywhere nationwide during the three-year contract term, CMS' proposed regulation says

Related Content

UsernamePublicRestriction

Register

PS043119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel